NewLimit
Developer of precision medicines designed for epigenetic reprogramming to restore youthful function in aging cells. The company applies single-cell genomics, machine learning, and functional assays to...
Valuation
$1.6B
Latest known
Share Price
N/A
Total Raised
$247.3M
Last Round
N/A